SRM
Spermidine synthase
Also known as: SPEE_HUMAN, SPS1, SRML1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P19623
- Gene
- SRM
- Ensembl
- ENSG00000116649
- Chromosome
- 1
- Canonical length
- 302 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
The polyamines putrescine, spermine, and spermidine are ubiquitous polycationic mediators of cell growth and differentiation. Spermidine synthase is one of four enzymes in the polyamine-biosynthetic pathway and carries out the final step of spermidine biosynthesis. This enzyme catalyzes the conversion of putrescine to spermidine using decarboxylated S-adenosylmethionine as the cofactor. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
302 residues, UniProt reviewed canonical sequence.
>P19623|SRM
1 MEPGPDGPAA SGPAAIREGW FRETCSLWPG QALSLQVEQL LHHRRSRYQD ILVFRSKTYG
61 NVLVLDGVIQ CTERDEFSYQ EMIANLPLCS HPNPRKVLII GGGDGGVLRE VVKHPSVESV
121 VQCEIDEDVI QVSKKFLPGM AIGYSSSKLT LHVGDGFEFM KQNQDAFDVI ITDSSDPMGP
181 AESLFKESYY QLMKTALKED GVLCCQGECQ WLHLDLIKEM RQFCQSLFPV VAYAYCTIPT
241 YPSGQIGFML CSKNPSTNFQ EPVQPLTQQQ VAQMQLKYYN SDVHRAAFVL PEFARKALND
301 VSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SRM can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 184 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 184 nTPM
- skeletal muscle: 123 nTPM
- heart muscle: 84 nTPM
- basal ganglia: 83 nTPM
- blood vessel: 76 nTPM
- amygdala: 75 nTPM
Single-cell type
- plasma cells: 336 nCPM
- breast myoepithelial cells: 285 nCPM
- esophageal basal cells: 222 nCPM
- extravillous trophoblasts: 207 nCPM
- pancreatic acinar cells: 190 nCPM
- migrating cytotrophoblasts: 182 nCPM
Immune cell
- memory B-cell: 13 nTPM
- naive B-cell: 11 nTPM
- plasmacytoid DC: 11 nTPM
- MAIT T-cell: 11 nTPM
- naive CD8 T-cell: 10 nTPM
- memory CD8 T-cell: 9.3 nTPM
Brain region
- midbrain: 73 nTPM
- thalamus: 69 nTPM
- hippocampal formation: 67 nTPM
- hypothalamus: 65 nTPM
- cerebral cortex: 63 nTPM
- basal ganglia: 61 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.57
- gnomAD pLI
- 0.23
- gnomAD missense Z
- 2.55
- DepMap mean gene effect
- -0.18
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to leukemia inhibitory factor
- polyamine metabolic process
- spermidine biosynthetic process
Molecular functions
- identical protein binding
- protein homodimerization activity
- spermidine synthase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- S-adenosyl-L-methionine-dependent methyltransferase superfamily
- Polyamine biosynthesis domain, conserved site
- Polyamine biosynthesis domain
- Spermidine synthase, tetramerisation domain
- Spermidine synthase, tetramerisation domain superfamily
- Spermine/spermidine synthase domain
- Spermidine synthase tetramerisation domain
- Spermidine/spermine synthases
- Spermidine/spermine synthase, eukaryotes
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SRM as an antibody target. Whether an autoantibody or antibody against SRM could matter depends on whether native SRM is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SRM is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SRM as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...